Form 8-K Design Therapeutics, For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Design Therapeutics appoints David Shapiro to board of directors
April 1, 2026 4:06 PM EDTDesign Therapeutics Inc. (NASDAQ: DSGN) appointed David Shapiro, M.D., to its board of directors as a Class III director, effective March 31, 2026. His term will end at the company's 2027 annual meeting of stockholders.
Shapiro was also appointed to serve on the company's Nominating and... More
